Most Read Articles
Christina Lau, 22 Oct 2015
A 21-gene expression assay can identify patients with early-stage breast cancer who can skip adjuvant chemotherapy without facing an increased risk of recurrence at 5 years.

Podcast: Prof Robert Brodsky details findings of four of the late-breaking trials at ASH 2017

21 Dec 2017
Professor Robert Brodsky from Johns Hopkins University School of Medicine, and Secretary of ASH, details findings of four of the late-breaking trials: Hokusai VTE-Cancer (dalteparin), Murano (venetoclax), Alcyone (daratumumab), and Hercules (caplacizumab) trials. 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Christina Lau, 22 Oct 2015
A 21-gene expression assay can identify patients with early-stage breast cancer who can skip adjuvant chemotherapy without facing an increased risk of recurrence at 5 years.